微芯生物成立于2001年，专注于恶性肿瘤、代谢性疾病、自身免疫性疾病、中 枢神经系统疾病及抗病毒领域的原创新药研发，通过应用基于AI辅助设计和化学基 因组学的整合式技术平台，成功开发出全球首创且同类最优的原创新药，目前有2款 药物6个适应症获批上市； 6款产品处于临床阶段，多个具有差异化的新分子实体项 目持续推进。

Founded in 2001, Chipscreen Biosciences is a pioneer in drug innovation and development in China, focusing on the research and development of original newdrugs in the fields of malignant tumors, metabolic diseases, autoimmune diseases, central nervous system diseases and antiviral. Applying the integrated technology platform based on AI-driven design and chemical genomics,we have successfully developed two FIC and BIC innovative drugs, with six approved indications.Additionally, six products are in clinical-stage development, and a series of differentiated novel molecular entity projects are advancing steadily.

地址：广东省深圳市南山区西丽街道曙光社区智谷产业园 B栋21F-24F
21-24F, Block B, Zhigu Industrial Park, 3157 Shahe    West Road, Nanshan District, Shenzhen, Guangdong
电话：0755-36993562